Skip to main content
. 2022 Jan 3;11(4):931–943. doi: 10.1002/cam4.4521

FIGURE 3.

FIGURE 3

The combination therapies of mesenchymal stem cells (MSCs) for hepatocellular carcinoma (HCC). MSCs or their exosomes can be genetically modified (yellow) or combined with other treatments (purple) to inhibit the proliferation and progression of HCC cells through a variety of molecular signaling mechanisms (green)